deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT00513461

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

A Phase II, Randomized, Controlled Trial of The Safety and Efficacy of S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate (SAMe) in Reducing Serum Alpha-Fetoprotein (AFP) in Patients With Hepatitis C and Moderately Elevated AFP

Sponsor: Chao Family Comprehensive Cancer Center

Conditions Adult Primary Liver Cancer Hepatitis C Infection
Interventions S-adenosyl-L-methionine disulfate p-toluene-sulfonate high performance liquid chromatography immunoenzyme technique laboratory biomarker analysis placebo
Updated 9 times since 2017 Last updated: Aug 9, 2018 Started: Oct 31, 2007 Primary completion: Aug 31, 2012 Completion: Dec 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00513461, this PHASE2 trial focuses on Adult Primary Liver Cancer and Hepatitis C Infection and remains completed. Sponsored by Chao Family Comprehensive Cancer Center, it has been updated 9 times since 2007, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotUnknown Status~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotUnknown Status~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotUnknown Status~Sep 2018 – ~Jan 2021 · 28 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 21 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE2

▶ Show 4 earlier versions

  1. Sep 2018 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Unknown Status → Completed

  2. Jun 2018 — Sep 2018 [monthly]

    Unknown Status PHASE2

  3. Feb 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

  4. Jan 2017 — Feb 2017 [monthly]

    Unknown Status PHASE2

    First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chao Family Comprehensive Cancer Center
  • National Cancer Institute (NCI)
Data source: University of California, Irvine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations